Charles River Laboratories International, Inc. Common Stock (NY:CRL)

293.38 -6.92 (-2.30%)

Delayed Quote Updated: 9:49 AM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Charles River Laboratories Schedules Third-Quarter 2025 Earnings Release and Conference Call

October 14, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

3 Reasons to Avoid CRL and 1 Stock to Buy Instead

October 14, 2025

The past six months have been a windfall for Charles River Laboratories’s shareholders. The company’s stock price has jumped 60.1%, hitting $170.64 per share. This was partly due to its solid quarterly...

Via StockStory

Winners And Losers Of Q2: Charles River Laboratories (NYSE:CRL) Vs The Rest Of The Drug Development Inputs & Services Stocks

October 08, 2025

Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Charles River Laboratories (NYSE:CRL) and its peers.

Via StockStory

Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing

October 08, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Why Charles River Stock May Struggle In Its Final Phase ↗

October 07, 2025

Adhishthana.com notes Charles River Stock is nearing its Phase 18, with momentum weakening and long-term outperformance looking unlikely.

Via Benzinga

Charles River Laboratories (CRL) Stock Is Up, What You Need To Know

October 03, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 2.6% in the afternoon session after the stock's positive momentum continued, as Barclays upgraded the company to Overweight...

Via StockStory

What's going on in today's session: S&P500 movers ↗

October 02, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Thursday.

Via Chartmill

Why Charles River Laboratories (CRL) Stock Is Up Today

October 02, 2025

Shares of lab services company Charles River Laboratories (NYSE:CRL) jumped 1.9% in the morning session after Barclays upgraded the company to Overweight from Equal-Weight and raised its price target.

Via StockStory

Topics Government

Wondering what's happening in today's S&P500 pre-market session? ↗

October 02, 2025

Before the US market kicks off on Thursday, let's examine the pre-market session and unveil the notable performers among the S&P500 top gainers and losers.

Via Chartmill

7 Analysts Assess Charles River: What You Need To Know ↗

October 02, 2025

Via Benzinga

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years ↗

October 01, 2025

Health care stocks rallied after Trump struck a drug pricing deal with Pfizer, offering major discounts and pausing pharma tariffs.

Via Benzinga

Topics Government

Wednesday's session: top gainers and losers in the S&P500 index ↗

October 01, 2025

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Via Chartmill

Which S&P500 stocks are moving on Wednesday? ↗

October 01, 2025

Let's delve into the developments on the US markets in the middle of the day on Wednesday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.

Via Chartmill

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

What's going on in today's session: S&P500 movers ↗

September 30, 2025

Stay informed about the performance of the S&P500 index one hour before the close of the markets on Tuesday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Mr Wonderful Kevin O'Leary Says Bitcoin, Ethereum Enough To 'Capture The Promise' Of Crypto, Advises Against 'Irrelevant' Tokens ↗

September 18, 2025

Renowned investor Kevin O’Leary expressed his belief on Wednesday that owning only Bitcoin (CRYPTO: BTC) and Ethereum (CRYPTO: ETH) can capture the majority of the cryptocurrency market’s volat

Via Benzinga

Charles River Laboratories Announces Chief Financial Officer Transition

September 16, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Uncover the latest developments among S&P500 stocks in today's session. ↗

September 12, 2025

Curious about the top performers within the S&P500 index one hour before the close of the markets on Friday? Dive into the list of today's session's top gainers and losers for a comprehensive...

Via Chartmill

Exploring the top movers within the S&P500 index during today's session. ↗

September 12, 2025

Stay informed about the performance of the S&P500 index in the middle of the day on Friday. Uncover the top gainers and losers in today's session for valuable insights.

Via Chartmill

Charles River Collaborates to Enhance Oncology Manufacturing Portfolio, Advancing Research and Development of Cell and Gene Therapies to Treat Cancer

September 11, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

3 Unpopular Stocks That Concern Us

September 11, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

Breaking Down Charles River: 6 Analysts Share Their Views ↗

September 09, 2025

Via Benzinga

This Thomson Reuters Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

September 09, 2025

Via Benzinga

2 Cash-Producing Stocks Worth Your Attention and 1 We Brush Off

September 09, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 08, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

1 S&P 500 Stock with Exciting Potential and 2 We Brush Off

September 05, 2025

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth,...

Via StockStory

Topics Stocks

Charles River Enhances Cell Therapy Flex Platform through Collaboration with Akadeum Life Sciences

September 03, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Joins EASYGEN Consortium, Supports Development of Bedside CAR-T Manufacturing

August 26, 2025

From Charles River Laboratories International, Inc.

Via Business Wire

These S&P500 stocks are gapping in today's session ↗

August 21, 2025

Curious about the market action on Thursday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.

Via Chartmill

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.